Cesca Therapeutics aims its resources at research, development and marketing of autologous cell-based therapeutics for use in regenerative medicine. KOOL develops and manufactures automated blood and bone marrow processing systems that assist in the separation, processing and preservation of cell and tissue therapy products. Products include but are not limited to SurgWerks platform, a proprietary stem cell therapy.  For more information visit the company website at www.cescatherapeutics.com/